Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery

NCT05271708 is registered in ClinicalTrials.gov with National Defense Medical Center, Taiwan as lead sponsor.

NCT NCT05271708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05271708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explore the Short- and Mid-term Effects of Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery
Lead sponsor
National Defense Medical Center, Taiwan
Phase
Phase 4
Overall status
Completed
Start date
January 5, 2022
Completion date
November 30, 2022
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scar